Gfp,
You said:
"A seriously bad finding in the new studies, and CX-717 is toast. This is very unlikely, and we would have probably already heard something from Cortex".
Such a serious result should definitely have been identified by COR during the tests, thus the data would not have been submitted to the FDA. (Why would they?) Stranger things have happened I know, but if bad findings are uncovered in the submitted data then Stoll & company haven't been doing their job! I don't think this is anywhere near to being true!
My suspicion is that we're clean, but the FDA will take every milisecond of the thirty days. It's a show of power for a beaurocracy that has been under the gun for quite a while.
I predict the stockprice will be %$6.00/share by mid October, regardless of PIPE or any other associated shenanigans.